Article
SOX2 is a dose-dependent regulator of retinal neural progenitor competence.
Genes & development - 1 May 2006
Taranova Olena V, Magness Scott T, Fagan B Matthew, Wu Yongqin, Surzenko Natalie, Hutton Scott R, Pevny Larysa H
Abstract excerpt
Approximately 10% of humans with anophthalmia (absent eye) or severe microphthalmia (small eye) show haploid insufficiency due to mutations in SOX2, a SOXB1-HMG box transcription factor. However, at present, the molecular or cellular mechanisms responsible for these conditions are poorly understood. Here, we directly assessed the requirement for SOX2 during eye development by generating a gene-dosage allelic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
